The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Role of chemokines in the biology of natural killer cells
Abstract
Natural killer (NK) cells participate in innate and adaptive immuneresponses to obligate intracellular pathogens and malignant tumors. Twomajor NK cell subsets have been identified in humans:CD56dim CD16+ and CD56bright CD16−. RestingCD56dim CD16+ NK cells express CXCR1, CXCR2, CXCR3, CXCR4,and CX3CR1 but no detectable levels of CC chemokine receptors on thecell surface. They migrate vigorously in response to CXCL12 and CXC3L1. In contrast, resting CD56bright CD16− NK cells expresslittle CXCR1, CXCR2, and CXC3R1 but high levels of CCR5 and CCR7. Chemotaxis of CD56bright CD16− NK cells is stimulated mostpotently by CCL19, CCL21, CXCL10, CXCL11, and CXCL12. Followingactivation, NK cells can migrate in response to additional CC and CXCchemokines. Cytolytic activity of NK cells is augmented by CCL2, CCL3,CCL4, CCL5, CCL10, and CXC3L1. Moreover, proliferation of CD56dim CD16+ NK cells is costimulated by CCL19 and CCL21. Activated NK cells produce XCL1, CCL1, CCL3, CCL4, CCL5, CCL22, and CXCL8. Chemokines secreted by NK cells may recruit other effector cellsduring immune responses. Furthermore, CCL3, CCL4, and CCL5 produced byNK cells can inhibit in vitro replication of HIV. CCL3 and CXL10expression appear to be required for protective NK cell responses invivo to murine cytomegalovirus or Leishmania major,respectively. Moreover, NK cells participate in the in vivo rejectionof transduced tumor cells that produce CCL19 or CCL21. Thus, chemokinesappear to play an important role in afferent and efferent NK cellresponses to infected and neoplastic cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional diversity of helper T lymphocytes
Abbas, A. K., Murphy, K. M., & Sher, A. (1996) · Nature · doi:10.1038/383787a0 · Cited by 4,450
The biology of human natural killer-cell subsets
Cooper, M. A., Fehniger, T. A., & Caligiuri, M. A. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)02060-9 · Cited by 2,975
Biology of Natural Killer Cells
Trinchieri, G. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60664-1 · Cited by 2,902
The Biology of Chemokines and their Receptors
Rossi, D., & Zlotnik, A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.217 · Cited by 2,410
Förster, R., Schubel, A., Breitfeld, D., Kremmer, E., Renner-Müller, I., Wolf, E., & Lipp, M. (1999) · Cell · doi:10.1016/s0092-8674(00)80059-8 · Cited by 2,367
Grimm, E. A., Mazumder, A., Zhang, H. Z., & Rosenberg, S. A. (1982) · The Journal of experimental medicine · doi:10.1084/jem.155.6.1823 · Cited by 2,204
Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease
Berger, E. A., Murphy, P. M., & Farber, J. M. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.657 · Cited by 2,180
Rollins, B. J. (1997) · Blood · doi:10.1182/blood.v90.3.909 · Cited by 1,984
Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated Cytolysis
Moretta, A., Bottino, C., Vitale, M., Pende, D., Cantoni, C., Mingari, M. C., Biassoni, R., & Moretta, L. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.197 · Cited by 1,778
Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset
Cooper, M. A., Fehniger, T. A., Turner, S. C., Chen, K. S., Ghaheri, B. A., Ghayur, T., Carson, W. E., & Caligiuri, M. A. (2001) · Blood · doi:10.1182/blood.v97.10.3146 · Cited by 1,449
Imai, T., Hieshima, K., Haskell, C., Baba, M., Nagira, M., Nishimura, M., Kakizaki, M., Takagi, S., Nomiyama, H., Schall, T. J., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80438-9 · Cited by 1,445
Qin, S., Rottman, J. B., Myers, P., Kassam, N., Weinblatt, M., Loetscher, M., Koch, A. E., Moser, B., & Mackay, C. R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1422 · Cited by 1,359
Cosman, D., Müllberg, J., Sutherland, C. L., Chin, W., Armitage, R., Fanslow, W., Kubin, M., & Chalupny, N. J. (2001) · Immunity · doi:10.1016/s1074-7613(01)00095-4 · Cited by 1,232
Carson, W. E., Giri, J. G., Lindemann, M. J., Linett, M. L., Ahdieh, M., Paxton, R., Anderson, D., Eisenmann, J., Grabstein, K., & Caligiuri, M. A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.4.1395 · Cited by 1,092
Gunn, M. D., Tangemann, K., Tam, C., Cyster, J. G., Rosen, S. D., & Williams, L. T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.258 · Cited by 1,001
Biology and clinical relevance of human natural killer cells
Robertson, M., & Ritz, J. (1990) · Blood · doi:10.1182/blood.v76.12.2421.2421 · Cited by 931
Self-citationRecombinant IL-12 administration induces tumor regression in association with IFN- gamma production.
Nastala, C. L., Edington, H. D., McKinney, T. G., Tahara, H., Nalesnik, M. A., Brunda, M. J., Gately, M. K., Wolf, S. F., Schreiber, R. D., Storkus, W. J., et al. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.4.1697 · Cited by 780
Comparative studies of human FcRIII-positive and negative natural killer cells.
Nagler, A., Lanier, L. L., Cwirla, S., & Phillips, J. H. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.10.3183 · Cited by 696
Fehniger, T. A., Shah, M. H., Turner, M. J., VanDeusen, J. B., Whitman, S. P., Cooper, M. A., Suzuki, K., Wechser, M., Goodsaid, F., & Caligiuri, M. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.8.4511 · Cited by 652
Scharton, T. M., & Scott, P. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.2.567 · Cited by 608
Campbell, J. J., Qin, S., Unutmaz, D., Soler, D., Murphy, K. E., Hodge, M. R., Wu, L., & Butcher, E. C. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6477 · Cited by 517
Godiska, R., Chantry, D., Raport, C. J., Sozzani, S., Allavena, P., Leviten, D., Mantovani, A., & Gray, P. W. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.9.1595 · Cited by 476
Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10
Sgadari, C., Angiolillo, A., & Tosato, G. (1996) · Blood · doi:10.1182/blood.v87.9.3877.bloodjournal8793877 · Cited by 469
Siegel, J. P., & Puri, R. K. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.4.694 · Cited by 465
Orange, J. S., Wang, B., Terhorst, C., & Biron, C. A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.4.1045 · Cited by 455
Alpha and β chemokines induce NK cell migration and enhance NK-mediated cytolysis
Taub, D. D., Sayers, T. J., Carter, C. R., & Ortaldo, J. R. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.8.3877 · Cited by 449
Caligiuri, M. A., Zmuidzinas, A., Manley, T. J., Levine, H., Smith, K. A., & Ritz, J. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.5.1509 · Cited by 435
Yoshie, O., Imai, T., & Nomiyama, H. (2001) · Advances in Immunology · doi:10.1016/s0065-2776(01)78002-9 · Cited by 429
Scharton-Kersten, T., Afonso, L. C. C., Wysocka, M., Trinchieri, G., & Scott, P. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.10.5320 · Cited by 414
Salazar-Mather, T. P., Orange, J. S., & Biron, C. A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.1.1 · Cited by 375
Reiner, S. L., Zheng, S., Wang, Z. E., Stowring, L., & Locksley, R. M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.2.447 · Cited by 363
Robertson, M. J., Soiffer, R. J., Wolf, S. F., Manley, T. J., Donahue, C., Young, D., Herrmann, S. H., & Ritz, J. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.3.779 · Cited by 354
Self-citationCharacterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia.
Robertson, M. J., Cochran, K., Cameron, C. A., Le, J. M., Tantravahi, R. V., & Ritz, J. (1996) · PubMed · Cited by 343
Self-citationChemokines: signal lamps for trafficking of T and B cells for development and effector function
Kim, C. H., & Broxmeyer, H. E. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.65.1.6 · Cited by 342
Coughlin, C. M., Salhany, K. E., Gee, M. S., LaTemple, D. C., Kotenko, S., Ma, X., Gri, G., Wysocka, M., Kim, J. E., Liu, L., et al. (1998) · Immunity · doi:10.1016/s1074-7613(00)80585-3 · Cited by 324
Campbell, J. J., Bowman, E. P., Murphy, K., Youngman, K. R., Siani, M. A., Thompson, D. A., Wu, L., Zlotnik, A., & Butcher, E. C. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.4.1053 · Cited by 317
Rossi, D. L., Vicari, A. P., Franz-Bacon, K., McClanahan, T. K., & Zlotnik, A. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.3.1033 · Cited by 312
Tannenbaum, C. S., Tubbs, R., Armstrong, D., Finke, J. H., Bukowski, R. M., & Hamilton, T. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.2.927 · Cited by 294
Oliva, A., Kinter, A. L., Vaccarezza, M., Rubbert, A., Catanzaro, A., Moir, S., Monaco, J., Ehler, L., Mizell, S., Jackson, R., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2323 · Cited by 291
Induction of natural killer cell migration by monocyte chemotactic protein−1, −2 and −3
Allavena, P., Bianchi, G., Zhou, D., Van Damme, J., Jílek, P., Sozzani, S., & Mantovani, A. (1994) · European Journal of Immunology · doi:10.1002/eji.1830241249 · Cited by 291
Expression and regulation of chemokine receptors in human natural killer cells
Inngjerdingen, M., Damaj, B., & Maghazachi, A. A. (2001) · Blood · doi:10.1182/blood.v97.2.367 · Cited by 290
Frey, M., Packianathan, N. B., Fehniger, T. A., Ross, M. E., Wang, W.-C., Stewart, C. C., Caligiuri, M. A., & Evans, S. S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.1.400 · Cited by 287
Activation of NK cells by CC chemokines. Chemotaxis, Ca2+ mobilization, and enzyme release
Loetscher, P., Seitz, M., Clark-Lewis, I., Baggiolini, M., & Moser, B. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.1.322 · Cited by 282
Caligiuri, M. A., Murray, C., Robertson, M. J., Wang, E., Cochran, K., Cameron, C., Schow, P., Ross, M. E., Klumpp, T. R., & Soiffer, R. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116161 · Cited by 269
Self-citationAndrew, D. P., Chang, M.-S., McNinch, J., Wathen, S. T., Rihanek, M., Tseng, J., Spellberg, J. P., & Elias, C. G. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.5027 · Cited by 266
The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3
Soto, H., Wang, W., Strieter, R. M., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Hedrick, J., & Zlotnik, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8205 · Cited by 236
A chemokine-to-cytokine-to-chemokine cascade critical in antiviral defense
Salazar-Mather, T. P., Hamilton, T. A., & Biron, C. A. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9232 · Cited by 233
The enigma of the natural killer cell
Gumperz, J. E., & Parham, P. (1995) · Nature · doi:10.1038/378245a0 · Cited by 232
β Chemokines costimulate lymphocyte cytolysis, proliferation, and lymphokine production
Taub, D. D., Ortaldo, J. R., Turcovski-Corrales, S. M., Key, M. L., Longo, D. L., & Murphy, W. J. (1996) · Journal of Leukocyte Biology · doi:10.1002/jlb.59.1.81 · Cited by 222
Natural Killer Cells: From No Receptors to Too Many
Lanier, L. L. (1997) · Immunity · doi:10.1016/s1074-7613(00)80280-0 · Cited by 222
Robertson, M. J., Caligiuri, M. A., Manley, T. J., Levine, H., & Ritz, J. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.10.3194 · Cited by 218
Self-citationSuppression of tumor formation in vivo by expression of the JE gene in malignant cells.
Rollins, B. J., & Sunday, M. E. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.6.3125 · Cited by 217
Chuntharapai, A., Lee, J., Hébert, C. A., & Kim, K. J. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.12.5682 · Cited by 211
C-C chemokines induce the chemotaxis of NK and IL-2-activated NK cells. Role for G proteins.
Maghazachi, A. A., al-Aoukaty, A., & Schall, T. J. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.11.4969 · Cited by 202
Contribution of Natural Killer Cells to Inhibition of Angiogenesis by Interleukin-12
Yao, L., Sgadari, C., Furuke, K., Bloom, E. T., Teruya-Feldstein, J., & Tosato, G. (1999) · Blood · doi:10.1182/blood.v93.5.1612 · Cited by 201
Fractalkine-Mediated Endothelial Cell Injury by NK Cells
Yoneda, O., Imai, T., Goda, S., Inoue, H., Yamauchi, A., Okazaki, T., Imai, H., Yoshie, O., Bloom, E. T., Domae, N., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4055 · Cited by 192
Lymphotactin is produced by NK cells and attracts both NK cells and T cells in vivo
Hedrick, J. A., Saylor, V, Figueroa, D., Mizoue, L., Xu, Y., Menon, S., Abrams, J., Handel, T., & Zlotnik, A. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.4.1533 · Cited by 183
Drake, P. M., Gunn, M. D., Charo, I. F., Tsou, C.-L., Zhou, Y., Huang, L., & Fisher, S. J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.10.1199 · Cited by 175
Role of Interferon-γ in Mediating the Antitumor Efficacy of Interleukin-12
Brunda, M. J., Luistro, L., Hendrzak, J. A., Fountoulakis, M., Garotta, G., & Gately, M. K. (1995) · Journal of Immunotherapy · doi:10.1097/00002371-199502000-00001 · Cited by 164
CC chemokines induce the generation of killer cells from CD56+ cells
Maghazachi, A. A., Al‐Aoukaty, A., & Schall, T. J. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260207 · Cited by 163
Natural Killer Cells from HIV-1+ Patients Produce C-C Chemokines and Inhibit HIV-1 Infection
Fehniger, T. A., Herbein, G., Yu, H., Para, M. I., Bernstein, Z. P., O’Brien, W. A., & Caligiuri, M. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.11.6433 · Cited by 158
Antitumor Effects of the Mouse Chemokine 6Ckine/SLC Through Angiostatic and Immunological Mechanisms
Vicari, A. P., Aït‐Yahia, S., Chemin, K., Müeller, A., Zlotnik, A., & Caux, C. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.4.1992 · Cited by 156
Kubin, M. Z., Cassiano, L., Chalupny, J., Chin, W., Cosman, D. J., Fanslow, W. C., Müllberg, J., Rousseau, A.-M., Ulrich, D., & Armitage, R. J. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200105)31:5<1428::aid-immu1428>3.0.co;2-4 · Cited by 156
Inngjerdingen, M., Damaj, B. B., & Maghazachi, A. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4048 · Cited by 151
Bluman, E. M., Bartynski, K., Avalos, B. R., & Caligiuri, M. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118726 · Cited by 148
Principles and Practice of the Biologic Therapy of Cancer
Rosenberg, S. A. (2000) · Cited by 147
Baume, D. M., Robertson, M. J., Levine, H., Manley, T. J., Schow, P. W., & Ritz, J. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220102 · Cited by 145
Self-citationChemokine Regulation of Normal and Pathologic Immune Responses
Christopherson, K. W., & Hromas, R. (2001) · Stem Cells · doi:10.1634/stemcells.19-5-388 · Cited by 136
Braun, S. E., Chen, K., Foster, R. G., Kim, C. H., Hromas, R., Kaplan, M. H., Broxmeyer, H. E., & Cornetta, K. G. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4025 · Cited by 126
Romagnani, P., Annunziato, F., Lazzeri, E., Cosmi, L., Beltrame, C., Lasagni, L., Galli, G., Francalanci, M., Manetti, R., Marra, F., et al. (2001) · Blood · doi:10.1182/blood.v97.3.601 · Cited by 125
Costimulatory signals are required for optimal proliferation of human natural killer cells
Robertson, M. J., Manley, T. J., Donahue, C., Levine, H., & Ritz, J. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.5.1705 · Cited by 117
Self-citationKim, C. H., Pelus, L. M., Appelbaum, E. R., Johanson, K., Anzai, N., & Broxmeyer, H. E. (1999) · Cellular Immunology · doi:10.1006/cimm.1999.1483 · Cited by 106
Doherty, P. C. (1993) · Cell · doi:10.1016/0092-8674(93)90480-e · Cited by 105
Migratory response of human natural killer cells to lymphotactin
Giancarlo, B., Sozzani, S., Zlotnik, A., Alberto, M., & Allavena, P. (1996) · European Journal of Immunology · doi:10.1002/eji.1830261260 · Cited by 104
Morohashi, H., Miyawaki, T., Nomura, H., Kuno, K., Murakami, S., Matsushima, K., & Mukaida, N. (1995) · Journal of Leukocyte Biology · doi:10.1002/jlb.57.1.180 · Cited by 104
The Interferon-Inducible Chemokines MuMig and Crg-2 Exhibit Antiviral Activity In Vivo
Mahalingam, S., Farber, J. M., & Karupiah, G. (1999) · Journal of Virology · doi:10.1128/jvi.73.2.1479-1491.1999 · Cited by 102
André, P., Spertini, O., Guia, S., Rihet, P., Dignat‐George, F., Brailly, H., Sampol, J., Anderson, P., & Vivier, É. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3400 · Cited by 101
Mainiero, F., Soriani, A., Strippoli, R., Jacobelli, J., Gismondi, A., Piccoli, M., Frati, L., & Santoni, A. (2000) · Immunity · doi:10.1016/s1074-7613(00)80154-5 · Cited by 100
Yoshida, R., Nagira, M., Imai, T., Baba, M., Takagi, S., Tabira, Y., Akagi, J., Nomiyama, H., & Yoshie, O. (1998) · International Immunology · doi:10.1093/intimm/10.7.901 · Cited by 100
Roles of Chemokines and Receptor Polarization in NK-Target Cell Interactions
Nieto, M., Navarro, F., Pérez‐Villar, J. J., del Pozo, M. Á., González‐Amaro, R., Mellado, M., Rodríguez-Frade, J. M., Martínez‐A, C., López‐Botet, M., & Sánchez‐Madrid, F. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3330 · Cited by 99
Interleukin 12: Basic Biology and Potential Applications in Cancer Treatment
Robertson, M. J., & Ritz, J. (1996) · The Oncologist · doi:10.1634/theoncologist.1-1-88 · Cited by 98
Self-citationEarly Gene Expression of NK Cell-Activating Chemokines in Mice Resistant toLeishmania major
Vester, B., Müller, K., Solbach, W., & Laskay, T. (1999) · Infection and Immunity · doi:10.1128/iai.67.6.3155-3159.1999 · Cited by 76
Participation of the CD94 Receptor Complex in Costimulation of Human Natural Killer Cells
Voss, S. D., Daley, J. F., Ritz, J., & Robertson, M. J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.4.1618 · Cited by 73
Self-citationManome, Y., Wen, P. Y., Hershowitz, A., Tanaka, T., Rollins, B. J., Kufe, D. W., & Fine, H. A. (1995) · Cancer Immunology Immunotherapy · doi:10.1007/bf01516997 · Cited by 63
Nomura, T., Hasegawa, H., Kohno, M., Sasaki, M., & Fujita, S. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(200002)9999:9999<::aid-ijc1107>3.0.co;2-j · Cited by 58
Al-Aoukaty, A., Schall, T. J., & Maghazachi, A. A. (1996) · Blood · doi:10.1182/blood.v87.10.4255.bloodjournal87104255 · Cited by 55
Robertson, M. J., Cameron, C. A., Lazo, S., Cochran, K., Voss, S. D., & Ritz, J. (1996) · PubMed · Cited by 51
Self-citationNokihara, H., Yanagawa, H., Nishioka, Y., Yano, S., Mukaida, N., Matsushima, K., & Sone, S. (2000) · PubMed · Cited by 49
Activating Ly-49 NK Receptors: Central Role in Cytokine and Chemokine Production
Ortaldo, J. R., Bere, E. W., Hodge, D. L., & Young, H. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.8.4994 · Cited by 48
Robertson, M. J., Williams, B. T., Christopherson, K. W., Brahmi, Z., & Hromas, R. (2000) · Cellular Immunology · doi:10.1006/cimm.1999.1601 · Cited by 47
Self-citationConsiderations for the Use of Cytokine-Secreting Tumor Cell Preparations for Cancer Treatment
Vieweg, J., & Gilboa, E. (1995) · Cancer Investigation · doi:10.3109/07357909509011690 · Cited by 43
Somersalo, K., Carpén, O., & SAKSELA, E. (1994) · European Journal of Immunology · doi:10.1002/eji.1830241206 · Cited by 32
Park, J., Gruys, M. E., McCormick, K., Lee, J., Subleski, J. J., Wigginton, J. M., Fenton, R. G., Wang, J.-M., & Wiltrout, R. H. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.3763 · Cited by 30
(1999) · Humana Press eBooks · doi:10.1007/978-1-59259-701-7 · Cited by 18
Cited by
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
Cossarizza, A., Chang, H., Radbruch, A., Acs, A., Adam, D., Adam‐Klages, S., Agace, W. W., Aghaeepour, N., Akdis, M., Allez, M., et al. (2019) · European Journal of Immunology · doi:10.1002/eji.201970107 · Cited by 979
Roles for chemokines in liver disease
Marra, F., & Tacke, F. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.06.043 · Cited by 829
Bachelerie, F., Ben-Baruch, A., Burkhardt, A. M., Combadiere, C., Farber, J. M., Graham, G. J., Horuk, R., Sparre-Ulrich, A. H., Locati, M., Luster, A. D., et al. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.007724 · Cited by 850
Benson, D. M., Bakan, C. E., Mishra, A., Hofmeister, C. C., Efebera, Y., Becknell, B., Baiocchi, R. A., Zhang, J., Yu, J., Smith, M. K., et al. (2010) · Blood · doi:10.1182/blood-2010-02-271874 · Cited by 807
Natural killer cells and dendritic cells: rendezvous in abused tissues
Moretta, A. (2002) · Nature Reviews Immunology · doi:10.1038/nri956 · Cited by 704
Metadata
- Authors
- Robertson, M. J.
- Venue
- Journal of Leukocyte Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-02-01
- Volume
- 71
- Issue
- 2
- Pages
- 173-183
- ISSN
- 0741-5400 (ISSN-L)
- 1938-3673
- OpenAlex
- W2336153715
- Cited by
- 516
- References
- 94
- FWCI
- 7.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.